Clinical trials
Recruiting Amyloidosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2020 | 2 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| Brigham and Women's Hospital | 1 |
| Massachusetts General Hospital | 1 |
| Nanjing University School of Medicine | 1 |
| Peking University First Hospital | 1 |
| Universitair Ziekenhuis Brussel | 1 |
| University Hospital, Montpellier | 1 |
| University Hospital, Toulouse | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 8 |
| Immunoglobulin Light-chain Amyloidosis | 3 |
| Heart Failure | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Cardiomyopathies | 1 |
| Heart Failure, Diastolic | 1 |
| Polyneuropathies | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.